Skip to Content
Scientific Programs
Search this site
Main
Program for the Assessment of Clinical Cancer Tests (PACCT)
Strategic Partnering to Evaluate Cancer Signatures (SPECS)
SPECS I Projects
Shared Pathology Informatics Network (SPIN)
Last Updated:
11/15/11
Progress
PACCT strategy group
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Guidelines for marker development draft
Performance Standards Required for Essential Assays in Clinical Trials
Program Announcements for:
Phased Innovation Research in Cancer Prognosis and Prediction (R21/R33) PA-06-434
Phase II Developmental Research in Cancer Prognosis and Prediction (R33) PA-06-435
CBCTR breast cancer progression tissue micro-arrays
http://cdp.nci.nih.gov/breast/breast.html
Workshop in conjunction with the National Institutes of Standards and Technology to assess need for a HER2 standard reference material, April 2002.
< Previous
|
Next >